Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genenta Science S.p.A. - American Depositary Shares
(NQ:
GNTA
)
4.245
+0.075 (+1.80%)
Streaming Delayed Price
Updated: 10:48 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Genenta Science S.p.A. - American Depositary Shares
< Previous
1
2
Next >
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.
Via
InvestorPlace
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 36th Annual Roth Conference
March 01, 2024
Via
Investor Brand Network
This Small Cap Cancer Company 'Hijacks Tumors From Within," HC Wainwright Says
July 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 12, 2024
Via
Benzinga
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
February 08, 2024
Based on Preliminary Data from Ongoing Dose Ranging Stage of the Phase 1/2 Clinical Trial
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 22, 2023
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.
Via
Benzinga
Genenta to Present at Upcoming Scientific and Investor Conferences
September 06, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
July 28, 2023
Company Selects Refractory Advanced Genitourinary Malignancies including Renal Cell Cancer as Second Indication
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
June 29, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta to Provide Update on Lead Product Temferon™
May 16, 2023
Prof. Luigi Naldini will present updates on the efficacy of Temferon in pre-clinical solid tumor models and preliminary clinical biological data confirming in patients
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
April 26, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 35th Annual Roth Conference
February 22, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 14, 2023
Via
Benzinga
Genenta Sciences (NASDAQ: GNTA) Featured in Virtual Coverage of Roth’s Healthcare Opportunities Conference
September 29, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Intraday Session
September 16, 2022
Via
Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
July 25, 2022
Upgrades
Via
Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 28, 2022
Gainers
Via
Benzinga
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
September 08, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
Via
Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
June 28, 2022
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
June 29, 2022
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 23, 2022
Via
Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...
Via
Benzinga
Genenta Science (NASDAQ: GNTA) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 07, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's Intraday Session
March 03, 2022
Gainers Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 49.1% to $0.28 during Thursday's regular session. As of 12:31 EST, Tonix Pharmaceuticals's stock is trading...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 25, 2022
During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.